This feels off. In medicine, any evidence can also be blinded by confounding factors that are far easier to miss without adding specific controls. Really, in any field this will be the case.
Should we demand an RCT before we accept evidence? Of course not. At some point you do have to make a choice on things.
And it should be noted that most drugs do have early cutoff criteria if the evidence is strong enough that it is working. It isn't like people are wanting to withhold good treatments from the world. Adding controls and randomizing them, though, has proven to be highly effective at helping progress.
> "This feels off. In medicine, any evidence can also be blinded by confounding factors that are far easier to miss without adding specific controls. Really, in any field this will be the case."
If you have enough data, you can smooth out individual fluctuations due to things like drug interactions, non-compliance, etc. (And indeed you might discover drug interactions!) Observational trials ultimately mirror how drugs are used in the real world.
> "Adding controls and randomizing them, though, has proven to be highly effective at helping progress."
I would argue just the opposite. Demands for increasingly byzantine trials have ballooned the costs associated with drug development, and have slowed things to a crawl. There's a reason the field's golden age was in the 1940s and 1950s, and it's not just "low hanging fruit." Today nobody in their right mind wants to work in drug development when they could work in tech or even finance.